Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy (Q33979204)
scientific article
Language:
(P31) (Q13442814)
(P304) 1029-1034
(P407) (Q1860)
(P433) 4
(P478) 44
(P577) Saturday, April 1, 2000
(P921) (Q423984)
(Q425490)
(Q422606)
(P1433) (Q578004)
(P1476) "Pharmacologic characteristics of indinavir, didanosine, and stavudine in human immunodeficiency virus-infected children receiving combination therapy" (language: en)
(P2093) C V Fletcher
R C Brundage
R P Remmel
L M Page
D Weller
N R Calles
C Simon
M W Kline
(P2860) (Q43506115)
(Q40852809)
(Q45756781)
(Q45770259)
(Q45858554)
(Q45860738)
(Q44151661)
(Q52306238)
(Q43667219)
(Q45787765)
(Q74510703)
(Q77550442)
other details
description scientific article

External Links